AnalystsKumaraguru Raja
Kumaraguru Raja's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 2%
#4813 out of 4868 analysts
Average Return
-63.49%
Win Rate
0%0 out of 20
Risk vs Reward
Poor
Good

Kumaraguru Raja's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
No Ratings Available
Kumaraguru Raja doesn't have any winning ratings in our database

Kumaraguru Raja Analyst Color

Get additional color on Kumaraguru Raja's coverage of popular stocks

Kumaraguru Raja's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Quince Therapeutics IncQNCX
1Strong Buy$9.00+718.18%Initiates Coverage On
4 months ago
Palisade Bio IncPALI
1Strong Buy$38.00+4,796.91%Initiates Coverage On
5 months ago
Sab Biotherapeutics IncSABS
1Strong Buy$8.00+370.59%Initiates Coverage On
a year ago
Forte Biosciences IncFBRX
2Strong Buy$100.00+1,269.86%Initiates Coverage On
a year ago
Adial Pharmaceuticals IncADIL
2Strong Buy$150.00N/AReiterates
2 years ago
Genenta Science SpaGNTA
1Strong Buy$15.00N/AAssumes
2 years ago
Atyr Pharma IncATYR
1Strong Buy$9.00N/AReinstates
2 years ago
Rain Oncology IncRAIN2
1Strong Buy$21.00N/AReinstates
2 years ago
Apexigen IncAPGN
1Strong Buy$15.00N/AReinstates
2 years ago
Monopar TherapeuticsMNPR
2Strong Buy$90.00N/AReinstates
2 years ago
Veru IncVERU
1Strong Buy$31.00N/AMaintains
3 years ago
Dermata Therapeutics IncDRMA
1Strong Buy$3,360.00N/AInitiates Coverage On
4 years ago
Oncternal Therapeutics IncONCT
1Strong Buy$320.00N/AInitiates Coverage On
4 years ago
9 Meters Biopharma IncNMTRQ
1Strong Buy$120.00N/AAssumes
4 years ago
Nls Pharmaceutics LtdNLSP
1Strong Buy$480.00N/AInitiates Coverage On
4 years ago
Lisata Therapeutics IncLSTA
1Strong Buy$10.00N/AMaintains
4 years ago
Cns Pharmaceuticals IncCNSP
1Strong Buy$15,000.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.